ArticleFrontiers in oncology2022

eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma.

Fangyingnan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.